G. Irving

发表

The role of the skin in peripheral neuropathic pain

G. Irving, 2010 .

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.

G. Bennett, D. Fishbain, B. Mccarberg, 2006, Mayo Clinic proceedings.

The immediate and delayed effects of marathon running on renal function.

T. Noakes, R. V. Zyl-Smit, G. Irving, 1986, The Journal of urology.

Beta‐adrenergic blockade restores glucose's antiketogenic activity after exercise in carbohydrate‐depleted athletes.

R. Sandell, J. H. Koeslag, G. Irving, 1987, The Journal of physiology.

Perioperative blood and blood component therapy

G. Irving, 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Continuing Medical Education Perioperative blood and blood component therapy

G. Irving, 1992 .

Comparison of Duloxetine anD pregabalin in Dpnp

V. Skljarevski, R. Risser, M. Robinson, 2011 .

New trends in opioid analgesics

G. Irving, 1997 .

Long-term Safety of Gastroretentive Gabapentin in Postherpetic Neuralgia Patients

M. Jensen, M. Wallace, R. Rauck, 2013, The Clinical journal of pain.

Description and predictors of direct and indirect costs of pain reported by cancer patients.

J. Ashley, B. Fortner, G. Irving, 2003, Journal of pain and symptom management.

The Rationale and Use of Anti-Inflammatories and Pain Killers in the Rehabilitation of Sports Iniuries

G. Irving, 1989 .

Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians

G. Irving, 2012, Therapeutic advances in chronic disease.

The cognitive effects of opioids.

M. Cherrier, M. Ersek, G. Irving, 2004, Pain management nursing : official journal of the American Society of Pain Management Nurses.

Contemporary assessment and management of neuropathic pain

G. Irving, 2005, Neurology.

Targeting the Skin for Treating Peripheral Neuropathic Pain (Industry Symposium Sponsored by Astellas)

G. Irving, 2010 .

Rational multidrug therapy in the treatment of neuropathic pain

C. Argoff, M. Backonja, G. Irving, 2006, Current pain and headache reports.

Long-term outcome of five cases of corticosteroid-responsive meningomyelitis.

G. Irving, C. Chrisman, 1990 .

Quantitative Sensory Testing and Mapping: A Review of Nonautomated Quantitative Methods for Examination of the Patient With Neuropathic Pain

Robert R. Edwards, Mark Wallace, Misha-Miroslav Backonja, 2009, The Clinical journal of pain.

Anaesthesia for burns in children: a review of procedures practised at Red Cross War Memorial Children's Hospital, Cape Town.

G. Irving, A. Butt, 1994, Burns : journal of the International Society for Burn Injuries.

Quantitative Assessment of Differential Sensory Blockade After Lumbar Epidural Lidocaine

M. Wallace, G. Irving, Beng Tay, 1996, Regional Anesthesia & Pain Medicine.

The protective role of local hypothermia in tourniquet-induced ischaemia of muscle.

T. Noakes, G. Irving, 1985, The Journal of bone and joint surgery. British volume.

A comparison of caudal morphine given pre‐ or postsurgery for postoperative analgesia in children

G. Irving, B. Veen, A. Butt, 1993 .

Management of Chronic Noncancer Pain in Depressed Patients

R. Barkin, A. Gordon, G. Irving, 2011, Postgraduate medicine.

Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia

M. Wallace, V. Cowles, G. Irving, 2010, Clinical drug investigation.

NGX-4010 , a Capsaicin 8 % Dermal Patch , Administered Alone or in Combination With Systemic Neuropathic Pain Medications , Reduces Pain in Patients With Postherpetic Neuralgia

L. Webster, J. Tobias, M. Backonja, 2011 .

Diabetic peripheral neuropathic pain: clinical and quality-of-life issues.

D. Fishbain, C. Argoff, B. E. Cole, 2006, Mayo Clinic proceedings.

A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

J. Tobias, M. Backonja, E. Blonsky, 2011, Pain medicine.

Safety and efficacy of NGX-4010, a prescription strength capsaicin 8% patch, for the management of postherpetic neuralgia (PHN) in the older population

L. Webster, J. Tobias, M. Backonja, 2011 .

A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.

J. Pénzes, E. Spierings, J. Wurzelmann, 2011, The journal of pain : official journal of the American Pain Society.

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

L. Webster, B. Morlion, J. Peppin, 2008, Pain.

The Placebo Response

G. Irving, 2010, Clinical drug investigation.

Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain

J. Raskin, R. Tanenberg, G. Irving, 2014, International journal of clinical practice.

Multimodal analgesia for chronic pain: rationale and future directions.

F. Rice, C. Argoff, P. Albrecht, 2009, Pain medicine.

Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.

V. Skljarevski, R. Risser, M. Robinson, 2011, Mayo Clinic proceedings.

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.

G. Bennett, D. Fishbain, B. Mccarberg, 2006, Mayo Clinic proceedings.

Laboratory Investigations, Imaging and Neurological Assessment in Pain Management

P. Squire, M. Backonja, D. Walk, 2010 .

Quantitative Sensory Testing in Measurement of Neuropathic Pain Phenomena and Other Sensory Abnormalities

N. Sehgal, R. Edwards, A. Wasan, 2009, The Clinical journal of pain.

Effects of Tourniquet Ischemia on Current Perception Thresholds in Healthy Volunteers

G. Irving, Georgeann C. Baron, 2002, Pain practice : the official journal of World Institute of Pain.

Efficacy and Tolerability of Gastric-retentive Gabapentin for the Treatment of Postherpetic Neuralgia: Results of a Double-blind, Randomized, Placebo-controlled Clinical Trial

M. Wallace, M. Jensen, M. Cramer, 2009, The Clinical journal of pain.

Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

M. Wallace, R. Rauck, M. Sweeney, 2013, Journal of pain and symptom management.

Painless Electrodiagnostic Current Perception Threshold and Pain Tolerance Threshold Values in CRPS Subjects and Healthy Controls: A Multicenter Study

B. Shahani, M. Brandstater, S. Glusman, 2001, Pain practice : the official journal of World Institute of Pain.

Painless electrodiagnostic current perception threshold and pain tolerance threshold values in CRPS subjects and healthy controls: a multicenter study.

B. Shahani, M. Brandstater, S. Glusman, 2001 .

The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials

M. Jaros, M. Buchfuhrer, N. Hermanowicz, 2016, CNS Drugs.

Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia

M. Sweeney, G. Irving, 2012, Journal of pain research.

Pain Management for the Practicing Physician

M. Wallace, G. Irving, 1996 .

A simple system to prevent epidural catheter hub disconnections.

G. Irving, D. Breznick, S. Artmann, 1997, Anesthesia and analgesia.

NEUROPATHIC PAIN SECTION Original Research Articles A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia

J. Tobias, M. Backonja, E. Blonsky, 2011 .

L. Webster, B. Morlion, J. Peppin, 2008, PAIN®.